These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3266475)
1. Synthesis of human thymopoietin (hTP) and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2506-16. PubMed ID: 3266475 [No Abstract] [Full Text] [Related]
2. Synthesis of the revised amino acid sequence of thymopoietin II and examination of its immunological effect on the impaired T-lymphocyte transformation of a uremic patient with pneumonia. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1987 May; 35(5):2016-24. PubMed ID: 3499238 [No Abstract] [Full Text] [Related]
3. Synthesis of human splenin (hSP) and examination of its immunological effects on the impaired T- and B-lymphocytes in uremic patients. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):487-91. PubMed ID: 2337963 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of [Phe(4F)3]thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients. Abiko T; Sekino H Bioorg Med Chem; 1995 Oct; 3(10):1369-75. PubMed ID: 8564403 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of [Glu34]human splenin (hSP) and examination of its immunological effect on the reduced B-lymphocytes of uremic patients. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):391-6. PubMed ID: 2787213 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of the nonatetracontapeptide corresponding to the entire amino acid sequence of thymopoietin III and its effect on the impaired T-lymphocyte transformation of a patient with common variable immunodeficiency. Abiko T; Shishido H; Sekino H Chem Pharm Bull (Tokyo); 1986 May; 34(5):2133-43. PubMed ID: 3488834 [No Abstract] [Full Text] [Related]
7. Syntheses and structure-activity relationships of thymopoietin. Abiko T Adv Exp Med Biol; 1987; 223():153-5. PubMed ID: 3447432 [No Abstract] [Full Text] [Related]
8. Synthesis of [I-NaI3]] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes. Abiko T; Nakatsubo S Mediators Inflamm; 2000; 9(3-4):201-6. PubMed ID: 11132780 [TBL] [Abstract][Full Text] [Related]
9. Syntheses and effects of human splenin (hSP) fragment 32-48 and an analog on the reduced B-lymphocytes of uremic patients. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2472-6. PubMed ID: 2605694 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of the nonatetracontapeptide corresponding to the entire amino acid sequence of thymopoietin I and its effect on the low E-rosette-forming cells of a uremic patient. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1583-91. PubMed ID: 4042234 [No Abstract] [Full Text] [Related]
11. Synthesis and effects of two peptide fragments of thymopoietin II on E-rosette forming cells in the uremic state. Abiko T; Kumikawa M; Sekino H Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2233-7. PubMed ID: 519816 [No Abstract] [Full Text] [Related]
12. Functional roles of phenylalanine(7) of thymic humoral factor-gamma 2 in the impaired blastogenic response of uremic T-lymphocytes. Abiko T; Sekino H Drug Dev Ind Pharm; 1998 Jun; 24(6):569-72. PubMed ID: 9876625 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of an immunologically active analog of thymic humoral factor-gamma 2 with enhanced enzymatic stability. Abiko T; Sekino H Bioorg Med Chem; 1994 Aug; 2(8):787-92. PubMed ID: 7894972 [TBL] [Abstract][Full Text] [Related]
14. Syntheses and immunological effects of thymic humoral factor-gamma 2 and its Phe7-substituted analogues. Abiko T; Sekino H Artif Organs; 1996 Aug; 20(8):853-6. PubMed ID: 8853795 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of the nonatetracontapeptide corresponding to the sequence proposed for thymopoietin II. Fujino M; Shinagawa S; Fukuda T; Takaoki M; Kawaji H Chem Pharm Bull (Tokyo); 1977 Jun; 25(6):1486-9. PubMed ID: 890863 [No Abstract] [Full Text] [Related]
16. Syntheses and effects of [Glu34]-thymopoietin II fragment 32-45 and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency. Abiko T; Shishido H; Sekino H Biotechnol Appl Biochem; 1986; 8(2-3):160-71. PubMed ID: 3488750 [TBL] [Abstract][Full Text] [Related]
17. The effect of thymopoietin II fragments and their analogs on E-rosette forming cells in the uremic state. Abiko T; Onodera I; Sekino H Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2507-11. PubMed ID: 7428129 [No Abstract] [Full Text] [Related]
18. Synthesis of the octadecapeptide corresponding to positions 32 to 49 of the revised amino acid sequence of thymopoietin II and its effect on low E-rosette forming cells of an aged patient with chronic renal failure. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3271-7. PubMed ID: 7172335 [No Abstract] [Full Text] [Related]
19. Synthesis of deacetyl-thymosin beta 7 and examination of its immunological effect on the blastogenic response of T-lymphocytes of a uremic patient with cell-mediated immunodeficiency. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):700-7. PubMed ID: 3261642 [No Abstract] [Full Text] [Related]
20. Synthesis of calf thymosin beta 4 fragment 16-38 and its effect on the impaired blastogenic response of T-lymphocytes of a uremic patient with pneumonia. Abiko T; Sekino H Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3757-65. PubMed ID: 3501734 [No Abstract] [Full Text] [Related] [Next] [New Search]